https://orcid.org/0000-0001-5783-6181
References
- de Bartolomeis A, Barone A, Vellucci L, et al. Linking inflammation, aberrant glutamate-dopamine interaction, and post-synaptic changes: Translational relevance for schizophrenia and antipsychotic treatment: A systematic review. Mol Neurobiol. 2022;59(10):6460–6501.
- Sibson NR, Dhankhar A, Mason GF, et al. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proceedings of the National Academy of Sciences. 1998;95(1):316–321.
- Fan L, Liang L, Wang Y, et al. Glutamatergic basis of antipsychotic response in first-episode psychosis: a dual voxel study of the anterior cingulate cortex. Neuropsychopharmacology. 2024;49(5):845–853. doi: 10.1038/s41386-023-01741-x
- Kantrowitz JT, Grinband J, Goff DC, et al. Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: rcts of pomaglumetad and ts-134 on ketamine-induced psychotic symptoms and pharmacobold in healthy volunteers. Neuropsychopharmacology. 2020;45(11):1842–1850. doi: 10.1038/s41386-020-0706-z
- Kruse AO, Bustillo JR Glutamatergic dysfunction in schizophrenia. Transl Psychiatry. 2022;12(1):500. 10.1038/s41398-022-02253-w
- McCutcheon RA, Krystal JH, Howes OD. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry. 2020;19(1):15–33. doi: 10.1002/wps.20693
- Uno Y, Coyle JT. Glutamate hypothesis in schizophrenia. Psychiatry Clin Neurosci. 2019;73(5):204–215.
- Rothman DL, de Graaf RA, Hyder F, et al. In vivo 13c and 1h‐[13c] mrs studies of neuroenergetics and neurotransmitter cycling, applications to neurological and psychiatric disease and brain cancer. NMR Biomed. 2019;32(10):e4172.
- Abdallah CG, De Feyter HM, Averill LA, et al. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects. Neuropsychopharmacology. 2018;43(10):2154–2160. doi: 10.1038/s41386-018-0136-3
- Averill LA, Jiang L, Purohit P, et al. Prefrontal glutamate neurotransmission in ptsd: A novel approach to estimate synaptic strength in vivo in humans. Chronic Stress. 2022;6:24705470221092734.10.1177/24705470221092734
- Hyder F, Rothman DL, Bennett MR. Cortical energy demands of signaling and nonsignaling components in brain are conserved across mammalian species and activity levels. Proceedings of the National Academy of Sciences. 2013;110(9):3549–3554.
- Moghaddam B, Javitt D From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 2012;37(1):4–15. 10.1038/npp.2011.181
- Chowdhury GM, Zhang J, Thomas M, et al. Transiently increased glutamate cycling in rat pfc is associated with rapid onset of antidepressant-like effects. Mol Psychiatry. 2017;22(1):120–126. doi: 10.1038/mp.2016.34
- Abdallah CG, Jiang L, De Feyter HM, et al. Glutamate metabolism in major depressive disorder. American Journal of Psychiatry. 2014;171(12):1320–1327.
- Chowdhury GM, Behar KL, Cho W, et al. 1h-[13c]-nuclear magnetic resonance spectroscopy measures of ketamine’s effect on amino acid neurotransmitter metabolism. Biol Psychiatry. 2012;71(11):1022–1025. doi: 10.1016/j.biopsych.2011.11.006